NEW YORK (Reuters) – Johnson & Johnson and a unit of Imerys SA must pay $117 million in damages to a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.
https://www.teleconsulteurope.com/wp-content/uploads/2014/11/teleconsult-logo-300x124.png00Reuters: Health Newshttps://www.teleconsulteurope.com/wp-content/uploads/2014/11/teleconsult-logo-300x124.pngReuters: Health News2018-04-11 21:21:282018-04-11 21:21:28Johnson & Johnson, Imerys must pay $117 million to New Jersey man in asbestos cancer case